NVCR vs. MELI
Compare and contrast key facts about NovoCure Limited (NVCR) and MercadoLibre, Inc. (MELI).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVCR or MELI.
Key characteristics
| NVCR | MELI | |
|---|---|---|
| YTD Return | 36.10% | 7.15% |
| 1Y Return | -73.89% | 29.85% |
| 3Y Return (Ann) | -51.70% | 8.39% |
| 5Y Return (Ann) | -16.62% | 23.16% |
| Sharpe Ratio | -0.83 | 0.83 |
| Daily Std Dev | 87.57% | 38.11% |
| Max Drawdown | -95.07% | -89.49% |
| Current Drawdown | -90.99% | -15.14% |
Fundamentals
| NVCR | MELI | |
|---|---|---|
| Market Cap | $1.77B | $85.88B |
| EPS | -$1.81 | $22.19 |
| PEG Ratio | -0.47 | 1.42 |
| Revenue (TTM) | $525.66M | $15.62B |
| Gross Profit (TTM) | $423.58M | $5.95B |
| EBITDA (TTM) | -$195.61M | $2.84B |
Correlation
The correlation between NVCR and MELI is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVCR vs. MELI - Performance Comparison
In the year-to-date period, NVCR achieves a 36.10% return, which is significantly higher than MELI's 7.15% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVCR vs. MELI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for NovoCure Limited (NVCR) and MercadoLibre, Inc. (MELI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVCR vs. MELI - Dividend Comparison
Neither NVCR nor MELI has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVCR NovoCure Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MELI MercadoLibre, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.19% | 0.38% | 0.36% | 0.52% | 0.53% |
Drawdowns
NVCR vs. MELI - Drawdown Comparison
The maximum NVCR drawdown since its inception was -95.07%, which is greater than MELI's maximum drawdown of -89.49%. Use the drawdown chart below to compare losses from any high point for NVCR and MELI. For additional features, visit the drawdowns tool.
Volatility
NVCR vs. MELI - Volatility Comparison
NovoCure Limited (NVCR) has a higher volatility of 19.82% compared to MercadoLibre, Inc. (MELI) at 10.39%. This indicates that NVCR's price experiences larger fluctuations and is considered to be riskier than MELI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVCR vs. MELI - Financials Comparison
This section allows you to compare key financial metrics between NovoCure Limited and MercadoLibre, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities